clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Carcinoma, Lewis Lung D018827 22 associated lipids
Fibrosis D005355 23 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Stomach Neoplasms D013274 24 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Nasal Polyps D009298 26 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Angina Pectoris D000787 27 associated lipids
Gastritis D005756 27 associated lipids
Endometriosis D004715 29 associated lipids
Proteinuria D011507 30 associated lipids
Drug Eruptions D003875 30 associated lipids
Diarrhea D003967 32 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Fever D005334 35 associated lipids
Heart Failure D006333 36 associated lipids
Lung Diseases D008171 37 associated lipids
Arthritis D001168 41 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Psoriasis D011565 47 associated lipids
Parkinson Disease D010300 53 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Pain D010146 64 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Colitis D003092 69 associated lipids
Hyperlipidemias D006949 73 associated lipids
Stomach Ulcer D013276 75 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Insulin Resistance D007333 99 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Xu Y et al. Synthesis and antibacterial activity of novel modified 5-O-mycaminose 14-membered ketolides. 2013 Eur J Med Chem pmid:24021890
Ranganathan D et al. Mycobacterium fortuitum peritonitis in a patient receiving continuous ambulatory peritoneal dialysis. 2013 Saudi J Kidney Dis Transpl pmid:24029271
de Zeeuw J et al. Serum levels of neopterin during antimicrobial treatment for Mycobacterium ulcerans infection. 2013 Am. J. Trop. Med. Hyg. pmid:23836576
Janković B et al. Consolidation trend design based on Young's modulus of clarithromycin single crystals. 2013 Int J Pharm pmid:23872226
Yoshida S et al. Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents. 2013 Int. J. Antimicrob. Agents pmid:23850022
Bismuth + metronidazole + tetracycline. Why risk adding bismuth? 2013 Prescrire Int pmid:23662315
Singh RP et al. Antimicrobial prophylaxis in open reduction and internal fixation of compound mandibular fractures: a collaborative regional audit of outcome. 2013 Br J Oral Maxillofac Surg pmid:23369782
Prasertpetmanee S et al. Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or for tailored therapy. 2013 Helicobacter pmid:23356886
Koh WJ et al. Reply: drug concentration monitoring in Mycobacterium avium lung disease: problems with methods and conclusions. 2013 Am. J. Respir. Crit. Care Med. pmid:23577353
Schmitt BH et al. PCR detection of clarithromycin-susceptible and -resistant Helicobacter pylori from formalin-fixed, paraffin-embedded gastric biopsies. 2013 Mod. Pathol. pmid:23579617
Asaoka D et al. Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area. 2013 Helicobacter pmid:23773231
Al-Haj A et al. Method development, validation and bioequivalence of varenicline in human plasma by liquid chromatography tandem mass spectrometry. 2013 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23774248
Faraji F et al. The effect of Helicobacter pylori eradication on migraine: a randomized, double blind, controlled trial. 2012 Nov-Dec Pain Physician pmid:23159967
Eremenko AA et al. [Effect of clarithromycin on the systemic inflammatory response syndrome severity in patients after myocardial revascularization surgery]. 2012 May-Jun Anesteziol Reanimatol pmid:22993930
Singh V et al. Vesicular palmoplantar pityriasis rosea. 2012 Mar-Apr Skinmed pmid:22545332
Gutiérrez-Castrellón P et al. Efficacy and safety of clarithromycin in pediatric patients with upper respiratory infections: a systematic review with meta-analysis. 2012 Mar-Apr Rev. Invest. Clin. pmid:22991774
Rajendiran S et al. Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment. 2012 Jul-Aug Saudi J Gastroenterol pmid:22824768
De Sanctis V et al. Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectum. 2012 Jul-Aug Tumori pmid:23052174
Figueroa M et al. [Antimicrobial susceptibility of Helicobacter pylori with chronic gastritis]. 2012 Jan-Mar Biomedica pmid:23235785
de Lalibera IB et al. Meningoencephalitis associated with Mycoplasma pneumoniae. 2012 Jan-Mar Einstein (Sao Paulo) pmid:23045836
Dhillon GS et al. Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients. 2012 Jan-Feb Clin Transplant pmid:21352378
Onsun N et al. Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment. 2012 Jan-Feb Eur J Dermatol pmid:22063790
Montero-Tinnirello J et al. [Pulmonary hemorrhage due to leptospirosis]. 2012 Jan-Feb Med Intensiva pmid:21592620
Dai WQ et al. The eradicating Helicobacter pylori infection in duodenal ulcer patients by three short-term triple therapies in China: a multicenter clinical comparative study. 2012 Jan-Feb Hepatogastroenterology pmid:22260837
VanderHeyden TR et al. Granulomatous hepatitis due to Bartonella henselae infection in an immunocompetent patient. 2012 BMC Infect. Dis. pmid:22269175
Ji R et al. Mucosal barrier defects in gastric intestinal metaplasia: in vivo evaluation by confocal endomicroscopy. 2012 Gastrointest. Endosc. pmid:22325805
[Experience with treatment of chronic polypoid rhinosinusitis using low doses of clarithromycin in the postoperative period]. 2012 Vestn. Otorinolaringol. pmid:22678641
Kim SY et al. Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea. 2012 Br J Clin Pharmacol pmid:21689141
Lotfy HM and Abdel-Monem Hagazy M Comparative study of novel spectrophotometric methods manipulating ratio spectra: an application on pharmaceutical ternary mixture of omeprazole, tinidazole and clarithromycin. 2012 Spectrochim Acta A Mol Biomol Spectrosc pmid:22683662
Rajper S et al. Macrolide and fluoroquinolone resistance in Helicobacter pylori isolates: an experience at a tertiary care centre in Pakistan. 2012 J Pak Med Assoc pmid:23866399
Salmon JH et al. Discitis and sacroiliitis diagnosed 15 years after iatrogenic Mycobacterium xenopi inoculation. 2012 Joint Bone Spine pmid:22405857
Katayama M et al. Interaction of clarithromycin with cyclosporine in cats: pharmacokinetic study and case report. 2012 J. Feline Med. Surg. pmid:22412163
Bobacheva TIu [The treatment of chronic polypous rhinosinusitis in the postoperative period with low doses of clarithromycin]. 2012 Vestn. Otorinolaringol. pmid:23011378
Omoruyi OJ et al. Metachronous Mycobacterium terrae complex tenosynovitis of the hand. 2012 J Hand Surg Eur Vol pmid:22415428
Ohe M and Hashino S Successful treatment of eosinophilic gastroenteritis with clarithromycin. 2012 Korean J. Intern. Med. pmid:23269887
Breda R et al. [Mycobacterium massiliense bone infection]. 2012 Med Mal Infect pmid:22154522
Zarogoulidis P et al. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. 2012 Eur. J. Clin. Pharmacol. pmid:22105373
Takahashi E et al. Oral clarithromycin enhances airway immunoglobulin A (IgA) immunity through induction of IgA class switching recombination and B-cell-activating factor of the tumor necrosis factor family molecule on mucosal dendritic cells in mice infected with influenza A virus. 2012 J. Virol. pmid:22896605
Bruin JP et al. Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates. 2012 Diagn. Microbiol. Infect. Dis. pmid:22100012
Chung JW et al. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial. 2012 J. Gastroenterol. Hepatol. pmid:22849546
van Ingen J et al. Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease. 2012 Int. J. Antimicrob. Agents pmid:22099521
Bondon-Guitton E et al. Drug-induced gingival overgrowth: a study in the French Pharmacovigilance Database. 2012 J. Clin. Periodontol. pmid:22519416
Vazquez-Lago JM et al. Attitudes of primary care physicians to the prescribing of antibiotics and antimicrobial resistance: a qualitative study from Spain. 2012 Fam Pract pmid:22016323
Bosnar M et al. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity. 2012 J. Med. Chem. pmid:22697905
Prechtl J et al. Monitoring of antibiotic resistance rates of Helicobacter pylori in Austrian children, 2002-2009. 2012 Pediatr. Infect. Dis. J. pmid:22094633
Deguchi R et al. Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy. 2012 J. Gastroenterol. Hepatol. pmid:22098133
Gao M et al. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. 2012 Urology pmid:22100490
Fujita J and Cash HL Long-term combination treatment of azithromycin with other macrolides: a new era. 2012 Intern. Med. pmid:22687831
Yamamoto Y et al. A case of refractory chronic respiratory tract infection due to Pseudomonas aeruginosa successfully controlled by combination of clarithromycin and azithromycin. 2012 Intern. Med. pmid:22687847
Espinal DA et al. [Human metapneumovirus in children: first cases in Colombia]. 2012 Biomedica pmid:23242289
Nishizawa T et al. Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy. 2012 J Clin Biochem Nutr pmid:22962528
Amin M et al. Green synthesis of silver nanoparticles through reduction with Solanum xanthocarpum L. berry extract: characterization, antimicrobial and urease inhibitory activities against Helicobacter pylori. 2012 Int J Mol Sci pmid:22949839
Kwan BY and Rabheru K Manic episode associated with clarithromycin in a patient with medically treated depression. 2012 Prim Care Companion CNS Disord pmid:22943025
Cheung JP et al. Mycobacterium marinum infection of the hand and wrist. 2012 J Orthop Surg (Hong Kong) pmid:22933682
Zong W et al. The first case of cutaneous infection with Mycobacterium parascrofulaceum. 2012 Ther Clin Risk Manag pmid:22930638
D'Elios MM et al. Helicobacter pylori: usefulness of an empirical fourth-line rifabutin-based regimen. 2012 Expert Rev Gastroenterol Hepatol pmid:22928895
Wu TS et al. Fish tank granuloma caused by Mycobacterium marinum. 2012 PLoS ONE pmid:22911774
Kim BJ et al. Discovery of a novel hsp65 genotype within Mycobacterium massiliense associated with the rough colony morphology. 2012 PLoS ONE pmid:22693637
Karczewska E et al. Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland. 2012 Gastroenterol Res Pract pmid:22693490
Tuchman SA et al. Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma. 2012 Adv Hematol pmid:22690220
Ojetti V et al. Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy. 2012 Gastroenterol Res Pract pmid:22690211
Dobrick N et al. [Legionnaires disease (legionella pneumonia)]. 2012 Praxis (Bern 1994) pmid:23147600
Uno K et al. Rupture of renal mycotic aneurysm that developed during the treatment of streptococcal infective endocarditis and vertebral osteomyelitis. 2012 Intern. Med. pmid:22687800
Ratcliffe AT and Ismail KM Intravenous macrolide use: a reminder of the dangers of rapid infusion rates. 2012 J Clin Anesth pmid:23101782
Sakinc T et al. Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin. 2012 BMC Res Notes pmid:23110798
Robinson P et al. Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial. 2012 Pediatr. Pulmonol. pmid:22266895
Korownyk C and Kolber MR Is quadruple therapy the new triple therapy for H pylori? 2012 Can Fam Physician pmid:22267623
Mumoli N and Cei M Clinical images: community-acquired pneumonia. 2012 CMAJ pmid:22271912
English ML et al. Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies. 2012 Antimicrob. Agents Chemother. pmid:22290969
Ogoshi T et al. A case of Good syndrome with pulmonary lesions similar to diffuse panbronchiolitis. 2012 Intern. Med. pmid:22576393
Tseng CH Diabetes, insulin use and Helicobacter pylori eradication: a retrospective cohort study. 2012 BMC Gastroenterol pmid:22571603
Park SK et al. Regression of Advanced Gastric MALT Lymphoma after the Eradication of Helicobacter pylori. 2012 Gut Liver pmid:22570759
Conde-Álvarez R et al. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. 2012 PLoS Pathog. pmid:22589715
Nakajima S et al. Multiple-antibiotic-resistant Helicobacter pylori infection eradicated with a tailor-made quadruple therapy. 2012 J. Gastroenterol. Hepatol. pmid:22486882
Buzás GM [Helicobacter pylori - 2012]. 2012 Orv Hetil pmid:22951408
Misiewicz JJ Management of Helicobacter pylori-related disorders. 2012 Eur J Gastroenterol Hepatol pmid:22498902
Sereni G et al. Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. 2012 World J. Gastroenterol. pmid:22969227
Bajaj P et al. Locally delivered 0.5% clarithromycin, as an adjunct to nonsurgical treatment in chronic periodontitis with well-controlled type 2 diabetes: a randomized controlled clinical trial. 2012 J Investig Clin Dent pmid:22976782
Pasqualetti G et al. Clarithromycin-induced rhabdomyolysis: a case report. 2012 Int J Gen Med pmid:22505827
Akelma AZ et al. Clarithromycin in treatment of acute asthma exacerbations: principles of appropriate antibiotic use. 2012 Pediatr Allergy Immunol pmid:22984834
Sachs G and Scott DR Helicobacter pylori: Eradication or Preservation. 2012 F1000 Med Rep pmid:22500191
Bataille S et al. Vancomycin-induced Henoch-Schönlein purpura: a case report. 2012 J Med Case Rep pmid:22490390
Pandya GJ et al. Unilateral lobar pulmonary edema. 2012 J Assoc Physicians India pmid:23547417
Buyck JM et al. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability. 2012 Clin. Infect. Dis. pmid:22573850
Shimizu T and Shimizu S Azithromycin inhibits mucus hypersecretion from airway epithelial cells. 2012 Mediators Inflamm. pmid:22577246
Farfan-Portet MI et al. Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data. 2012 Eur J Health Econ pmid:22427042
Mégraud F The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy. 2012 Therap Adv Gastroenterol pmid:22423259
Scheel AH et al. Talcum induced pneumoconiosis following inhalation of adulterated marijuana, a case report. 2012 Diagn Pathol pmid:22420484
Brüning J et al. Erythromycin A dimethyl sulfoxide disolvate 1.43-hydrate. 2012 Acta Crystallogr Sect E Struct Rep Online pmid:22412590
Noguchi S et al. Clarithromycin monohydrate: a synchrotron X-ray powder study. 2012 Acta Crystallogr Sect E Struct Rep Online pmid:22412567
Karne SS et al. Mycobacterium avium-intracellulare brain abscess in HIV-positive patient. 2012 Ann Indian Acad Neurol pmid:22412276
Yanai A et al. Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication: A randomized study in Japan. 2012 World J Gastrointest Pharmacol Ther pmid:22408744
Morisset J et al. A case of difficult-to-treat eosinophilic asthma controlled with clarithromycin. 2012 Ann. Allergy Asthma Immunol. pmid:22727169
Calza P et al. Identification of the unknown transformation products derived from clarithromycin and carbamazepine using liquid chromatography/high-resolution mass spectrometry. 2012 Rapid Commun. Mass Spectrom. pmid:22730089
Cronnolly B and Pegrum H Fentanyl-clarithromycin interaction. 2012 BMJ Case Rep pmid:22778456
Berti AD et al. Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics. 2012 Antimicrob. Agents Chemother. pmid:22802248
Khavinson VKh et al. Peptidergic regulation of expression of genes encoding antioxidant and anti-inflammatory proteins. 2012 Bull. Exp. Biol. Med. pmid:22803148
Polat Z et al. Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori. 2012 Eur. J. Intern. Med. pmid:22284248
Siqueira JF et al. Pyrosequencing as a tool for better understanding of human microbiomes. 2012 J Oral Microbiol pmid:22279602
O'Brien DP et al. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study. 2012 PLoS Negl Trop Dis pmid:22272368